Melanie Neary is a partner in the San Francisco office of Gibson, Dunn & Crutcher, where she practices in the firm’s Corporate Transactions Practice Group, focusing on representing leading life sciences companies and investors. Melanie advises clients on a wide range of complex transactions and matters, with a particular focus on financing transactions, including initial public offerings, secondary equity offerings and venture and growth equity financings, as well as complex corporate transactions, including mergers and acquisitions, spin-offs and PIPEs. Melanie regularly serves as principal outside counsel for numerous publicly-traded companies and advises management and boards of directors corporate law matters, Securities and Exchange Commission reporting requirements and ownership filings and corporate governance.
Melanie received her J.D. from the University of Michigan Law School in 2016, where she was the Managing Editor of the Michigan Business & Entrepreneurial Law Review. She earned her B.A., magna cum laude, in Communications, Legal Institutions, Economics and Government, with a minor in French, from American University in 2013.
Selected Experience
- Initial Public Offerings: Apogee Therapeutics, Rain Oncology, Shattuck Labs, Biora Therapeutics, 89bio, Cricut, StepStone Group, Petco Health and Wellness Company, Odonate Therapeutics, Excelerate Energy
- Follow-on Equity Offerings: Apogee Therapeutics, Spyre Therapeutics, Shattuck Labs, Biora Therapeutics, Protagonist Therapeutics, Ultragenyx Pharmaceutical, 89bio, Odonate Therapeutics, Rain Oncology, Rockwell Medical, Heron Therapeutics, Rocket Pharmaceuticals, StepStone Group, Leslie’s, Peloton, Eledon Pharmaceuticals, Viridian Therapeutics
- PIPE Offerings: Shattuck Labs, Viridian Therapeutics, Spyre Therapeutics, Dianthus Therapeutics, Biora Therapeutics
- ATM Facilities: Protagonist Therapeutics, Shattuck Labs, Rain Oncology, Biora Therapeutics, Ultragenyx, Viridian Therapeutics, 89bio, Rockwell Medical, California Water Service Group, Urovant
- Debt Offerings: Mauser Packaging, California Water Service Group, Wells Fargo & Company and Wells Fargo Bank, N.A., Gran Tierra Energy, Keysight Technologies, Magnite
- Venture Financings: Apogee Therapeutics – Series B, Cullgen – Series C, Perceive Biotherapeutics – Series B, Ellodi Pharmaceuticals – Series B, Tourmaline Bio – Series A, Jaanuu – Series B, Waterloo Sparkling Water – Series D, Bandier – Series E, ConnectRN – Series F, Sling Therapeutics – Series B
- Mergers and Acquisitions:
- Quidel in its acquisition of Ortho Clinical Diagnostics
- Glassdoor in its sale to Recruit Holdings
- BPGBio in its investment in Berg, LLC
- California Water Service Group in Proposed Acquisition of SJW Group
- Novus Therapeutics in merger transaction with Tokai Pharmaceuticals
- Rocket Pharmaceuticals in merger transaction with Inotek
Capabilities
- Capital Markets
- Emerging Companies / Venture Capital
- Fashion, Retail, and Consumer Products
- Life Sciences
- Media, Entertainment, and Technology
- Mergers and Acquisitions
- Securities Regulation and Corporate Governance
Credentials
Education:
- University of Michigan - 2016 Juris Doctor
- American University, Washington D.C. - 2013 Bachelor of Arts
Admissions:
- California Bar